Methylphenidate bioavailability from two extended-release formulations.

@article{Gonzlez2002MethylphenidateBF,
  title={Methylphenidate bioavailability from two extended-release formulations.},
  author={Mario A. Gonz{\'a}lez and Helen S. Pentikis and N Anderl and Michael F Benedict and Heleen H Decory and Sharon J Hirshey Dirksen and Simon J. Hatch},
  journal={International journal of clinical pharmacology and therapeutics},
  year={2002},
  volume={40 4},
  pages={
          175-84
        }
}
OBJECTIVE The objective of these studies was to compare the rate and extent of absorption of d,l-threo-methylphenidate (MPH) from two extended-release products--a capsule formulation containing coated beads and an OROS tablet formulation--in healthy male and female subjects under fasted conditions. MATERIALS Metadate CD (methylphenidate HCl, USP) Extended-Release Capsules and Concerta (methylphenidate hydrochloride) Extended-Release Tablets. METHODS Two studies were conducted: (1) A single… CONTINUE READING
Highly Cited
This paper has 49 citations. REVIEW CITATIONS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

Comparison of the pharmacokinetics and clinical efficacy of new extended-release formulations of methylphenidate.

Expert opinion on drug metabolism & toxicology • 2013
View 6 Excerpts
Highly Influenced